1. Introduction {#sec1-molecules-21-01362}
===============

Natural products contribute significantly to drug discovery research with a rich source of compounds and provide inherently large-scale of structural diversity than synthetic compounds \[[@B1-molecules-21-01362]\]. The genus *Paeonia* belongs to the family *Paeoniaceae* and consists of about thirty-three known species \[[@B2-molecules-21-01362]\]. The roots of *P. suffruticosa*, *P. obovata*, and *P. lactiflora* are important sources of crude drugs in traditional Chinese medication with activities of nitric oxide production inhibitory effects \[[@B3-molecules-21-01362],[@B4-molecules-21-01362]\], anti-tumor activity \[[@B5-molecules-21-01362],[@B6-molecules-21-01362]\], anti-inflammatory effects \[[@B7-molecules-21-01362]\], anti-influenza virus \[[@B8-molecules-21-01362]\], hematopoietic effects \[[@B9-molecules-21-01362]\], anti-aggregatoryand and anti-coagulative effects \[[@B10-molecules-21-01362]\].

2. Plant Distribution {#sec2-molecules-21-01362}
=====================

The genus *Paeonia* naturally distributes in the cold and temperate areas of the Northern Hemisphere. They are mainly distributed in Asia and Europe, and only a few native to Western North America. A total of 11 species are found in China, with wide distribution in southwestern and northwestern areas, central China, northern and northeastern China \[[@B11-molecules-21-01362]\].

In detail, *P. emodi* grows in the western Himalayas between Nepal and Pakistan \[[@B12-molecules-21-01362]\]. *P. obovata* naturally distributes in forests ranging from deciduous broad-leaved to coniferous forests and may be found at an altitude from 200 m to 2800 m. In China, it occurs in Anhui, Gansu, Guizhou, Hebei, and Heilongjiang et al. It also grows in Korea, Russia and Japan \[[@B13-molecules-21-01362]\]. In addition, *P. lactiflora* occurs in northern and northeastern China, Korea, Japan, Mongolia, Russia Far East and Siberia \[[@B14-molecules-21-01362]\]. *P. veitchii* distributes in western China including Shanxi, Gansu, Ningxia, Qinghai, Sichuan and the eastern rim of Tibet \[[@B15-molecules-21-01362]\]. *P. suffruticosa* grows in Central to Northern China including Tongling, Heze, Luoyang, Pengzhou, and Beijing \[[@B16-molecules-21-01362]\]. *P. delavayi* is endemic to southwestern China, where its habitat is limited to Sichuan, Yunnan and the very South-East of Tibet \[[@B17-molecules-21-01362]\].

3. Chemical Constituents {#sec3-molecules-21-01362}
========================

The present chemical studies of *Paeonia* plants were more focused on the composition of the roots and less on other parts. Since 1753 \[[@B18-molecules-21-01362]\], more than 180 compounds have been isolated. Nine species of the genus *Paeonia* have been chemically investigated, including *P. albiflora*, *P. delavayi*, *P. emodi*, *P. japonica*, *P. lactiflora*, *P. obovata*, *P. peregrina*, *P. suffruticosa*, *P. Veitchii*. Their flowers are shown below in [Figure 1](#molecules-21-01362-f001){ref-type="fig"}a--i. The skeletons of terpenoid compounds from this genus included monoterpenes, monoterpene glycosides and triterpenes. Their structures and names are summarized below (structures 1--108 and [Figure 2](#molecules-21-01362-f002){ref-type="fig"}, [Figure 3](#molecules-21-01362-f003){ref-type="fig"} and [Figure 4](#molecules-21-01362-f004){ref-type="fig"}). As shown, monoterpene glycosides are the important components in the genus *Paeonia*.

3.1. Monoterpenes {#sec3dot1-molecules-21-01362}
-----------------

Fourteen monoterpenes, 1--14, were isolated from *Paeonia* species. Paeoniflorin A (1) was obtained from the root cortex *P. suffruticosa* \[[@B19-molecules-21-01362]\]. Paeoniflorigenone (2), one of the main bioactive constituents, was found in three species, *P. suffruticosa*, *P.* *peregrina*, and *P. albiflora* \[[@B20-molecules-21-01362]\]. Most monoterpenes were obtained from *P.* *suffruticosa* \[[@B21-molecules-21-01362]\]. Three *p*-menthane monoterpenes, paeonilactone A--C (8, 9, and 11, resp.), were obtained from *P. albiflora*. In 1996, Paeonilactinone (5) and Lactinolide (12) were reported from *P.* *lactiflora* \[[@B22-molecules-21-01362]\]. Later, paeonilide (14) were found in *P. delavayi* \[[@B23-molecules-21-01362]\]. Their structures, 1--14, are shown below, and their names are collected in [Figure 2](#molecules-21-01362-f002){ref-type="fig"}.

3.2. Monoterpene Glycosides {#sec3dot2-molecules-21-01362}
---------------------------

A total of 58 monoterpene glycosides, 15--77, have been isolated from *Paeonia* species. Compounds 15--57 are pinane type derivatives with a variety of substituents \[[@B8-molecules-21-01362],[@B22-molecules-21-01362],[@B24-molecules-21-01362],[@B25-molecules-21-01362],[@B26-molecules-21-01362],[@B27-molecules-21-01362],[@B28-molecules-21-01362],[@B29-molecules-21-01362],[@B30-molecules-21-01362],[@B31-molecules-21-01362],[@B32-molecules-21-01362],[@B33-molecules-21-01362],[@B34-molecules-21-01362],[@B35-molecules-21-01362],[@B36-molecules-21-01362],[@B37-molecules-21-01362],[@B38-molecules-21-01362],[@B39-molecules-21-01362],[@B40-molecules-21-01362],[@B41-molecules-21-01362],[@B42-molecules-21-01362],[@B43-molecules-21-01362]\]. Later, 6-*O*-(β-[d]{.smallcaps}-glucopyranosyl)lactinolide (58), and lactiflorin (59) were obtained from *P. lactiflora* \[[@B44-molecules-21-01362]\]. *Paeonia* species are a rich source of monoterpene constituents possessing a "cage-like" pinane skeleton, which are found as the main biologically active compounds.

In 2012, 11 monoterpene glycosides, including, 4-*O*-methy-lmoudanpioside C (60), *p*-hydroxylbenzoyl-paeonidanin (61), 4-*O*-methylbenzoyl oxypaeoniflorin (62), paeoniflorin B (63), oxypaeoniflorin sulfonate (64), 4-*O*-methyloxypaeoniflorin (65), 4-*O*-methylgalloyloxy paeoniflorin (66), oxypaeonidanin (67), 9-epi-oxypaeonidanin (68), 9-*O*-butyloxypaeonidanin (69), 9-*O*-butylpaeonidanin (70), and 4-*O*-butyloxypaeoniflorin (71), were obtained from the ethanol extract of *P. suffruticosa Andrews* \[[@B4-molecules-21-01362]\]. They equally have "cage-like" pinane skeleton. In addition, in 2012, β-gentiobiosylpaeoniflorin (72), pyridylpaeoniflorin (73), (8*R*)-piperitone-4-en-9-*O*-β-[d]{.smallcaps}-gluco-pyranoside (74) are isolated from *P. suffruticosa* \[[@B45-molecules-21-01362]\]. In 2014, a new monoterpene glucoside, paeonin D (75), were obtained from *P. lactiflora* \[[@B46-molecules-21-01362]\]. In the same year, paeoniside A (76) and paeoniside B (77) were isolated from *P. suffruticosa* \[[@B47-molecules-21-01362]\]. Their structures, 15--77 are shown below, and their names are collected in [Figure 3](#molecules-21-01362-f003){ref-type="fig"}.

3.3. Triterpenes {#sec3dot3-molecules-21-01362}
----------------

A total of 30 triterpenes, 78--108, have been reported from various *Paeonia* species \[[@B44-molecules-21-01362],[@B48-molecules-21-01362],[@B49-molecules-21-01362],[@B50-molecules-21-01362],[@B51-molecules-21-01362],[@B52-molecules-21-01362],[@B53-molecules-21-01362]\]. Among them, compounds 78--80, 83--86, and 94--97 were isolated from the callus tissues of *P. suffruticosa*, *P. lactiflora*, and *P. japonica* \[[@B47-molecules-21-01362],[@B48-molecules-21-01362],[@B54-molecules-21-01362]\]. Later, four novel 24,30-dinortriterpenoids, 88--90 and 93, were only found in *P. delavayi* \[[@B17-molecules-21-01362]\]. In 2011, three noroleanane triterpenes 100--102 were obtained from *P. rockii* \[[@B50-molecules-21-01362]\]. In 2012, four noroleanane triterpenes 103--106 were obtained from *P. emodi* \[[@B55-molecules-21-01362]\]. In addition, in 2016, two new nortriterpenoids, paeonenoides D (107) and paeonenoides E (108), were obtained from *P. lactiflora* \[[@B56-molecules-21-01362]\]. Their structures, 78--108 are shown below, and their names are collected in [Figure 4](#molecules-21-01362-f004){ref-type="fig"}.

4. Biological Activities {#sec4-molecules-21-01362}
========================

4.1. Inhibitors of Nitric Oxide Production {#sec4dot1-molecules-21-01362}
------------------------------------------

Three compounds (1, 17 and 62) was showed significantly suppressed nitric oxide production \[[@B4-molecules-21-01362]\]. Paeoniflorin (15) inhibiting inflammation and inducible nitric oxide synthase signaling pathways, and ameliorates acute myocardial infarction of rat \[[@B3-molecules-21-01362]\]. Compounds 107, 108 were showed inhibitory effects against nitric oxide production in LPS-induced RAW246.7 macrophages \[[@B56-molecules-21-01362]\].

4.2. Anti-Tumor Activity {#sec4dot2-molecules-21-01362}
------------------------

A few of the compounds showed significant cytotoxicity against a panel of human cancer cell lines. Compound 95 against MCF-7, HT-29, M-14 \[[@B57-molecules-21-01362]\]; Compounds 104--106 against A549, HCT116, HL-60, ZR-75-30; Compounds 104--106 against HL-60, HCT116 and ZR-75-30 \[[@B58-molecules-21-01362]\]; Compounds 107, 108 against Hep-G2, SK-OV-3, HL-60 \[[@B56-molecules-21-01362]\].

4.3. Anti-Inflammatory Effects {#sec4dot3-molecules-21-01362}
------------------------------

Palbinone (99) have a strong inhibitory anti-inflammatory effect NF-κB signal pathway \[[@B52-molecules-21-01362]\]. Paeoniflorin (15) may ameliorate acute renal injury following ANP in rats by inhibiting inflammatory responses and renal cell apoptosis, due to the p38-MAPK and NF-κB \[[@B59-molecules-21-01362]\]. In addition, in 2016, Zhihong M. et al. reported it to have liver protective and anti-inflammatory effects in HCF diet-induced NASH rats, associated with inhibition of the ROCK and NF-κB in the NASH liver \[[@B7-molecules-21-01362]\]. In addition, paeoniside A (76) inhibited against cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes \[[@B47-molecules-21-01362]\].

4.4. Anti-Oxidative Effects {#sec4dot4-molecules-21-01362}
---------------------------

Compounds 28 and 29 have potent radical-scavenging remarkable effects on DPPH, and compounds 16 have a weak radical-scavenging effect \[[@B60-molecules-21-01362]\]. It is also demonstrated paeonins A (45) and paeonins B (46) exhibited inhibitory activities against lipoxygenase \[[@B40-molecules-21-01362]\]. Paeonin C (47) has potent inhibitory potential against lipoxygenase in a concentration-dependent fashion \[[@B61-molecules-21-01362]\]. Compounds 33 demonstrated a significant scavenging capacity against the DPPH free radical, ROS, the superoxide anion radical, and the hydroxyl radical \[[@B62-molecules-21-01362]\].

4.5. Anti-Aggregatory and Anti-Coagulative Effects {#sec4dot5-molecules-21-01362}
--------------------------------------------------

Paeonilide (14) selectively inhibited the platelet aggregation induced by platelet activating factor \[[@B23-molecules-21-01362]\]. Koo Y., et al. reported that paeoniflorin (15) and benzoylpaeoniflorin (17) have obvious inhibitory effect on collagen, endotoxin and adenosine diphosphate (ADP)-induced blood platelet coagulation, but not on blood aggregation in vitro. In addition, compounds 15 and 19 exhibited blood coagulation-inhibitory activity in vivo \[[@B10-molecules-21-01362]\].

4.6. Sedative and Analgesic {#sec4dot6-molecules-21-01362}
---------------------------

Paeoniflorin (15) could modulate sleep behaviors and the mechanisms involved, and increased NREM sleep by inhibiting the histaminergic system via A1 receptors \[[@B63-molecules-21-01362]\]. In addition, it could inhibit formalin-induced nociceptive behavior in mice, these effects may be might be associated with modulation of NMDA receptors, specifically the NR2B subunit \[[@B64-molecules-21-01362]\]. Shimizu et al. found that paeoniflorigenone (2) produced a blocking effect on neuromuscular junction in phrenic nerve diaphragm preparations of mice \[[@B65-molecules-21-01362]\]. In addition, paeonilactone C (9) was showed to suppress stimulated muscle twitchings of frog sciatic nerve-sartorius muscle \[[@B66-molecules-21-01362]\].

4.7. Other Activities {#sec4dot7-molecules-21-01362}
---------------------

Paeoniflorin (15) and 8-debenzoylpaeoniflorin (30) showed a blood sugar lowering effect in streptozotocin-treated rats \[[@B67-molecules-21-01362]\]. 1-*O*-(β-[d]{.smallcaps}-Glucopyranosyl)paeonisuffrone (55) was found to inhibit histamine release from rat peritoneal exudate cell-induced antigen-antibody reaction \[[@B22-molecules-21-01362]\]. Compound 52 was found to have a direct stimulatory effect on bone formation in vitro and may contribute to the prevention for osteoporosis \[[@B42-molecules-21-01362]\]. Paeoniflorin (15) has previously been reported to alleviate hepatic fibrosis. Paeoniflorin was found to effectively prevent renal interstitial fibrosis \[[@B68-molecules-21-01362]\]. Paeoniflorin (15) has sedative, hypotensive, and weak anti-inflammatory effects, and a preventive effect on stress ulcer \[[@B69-molecules-21-01362]\]. Compound 89 showed inhibitory activity against β-glucuronidase \[[@B70-molecules-21-01362]\].

5. Conclusions {#sec5-molecules-21-01362}
==============

*Paeonia* is the only genus in the family *Paeoniaceae* and has significant medicinal importance in traditional Chinese medicine. Researchers have different views on the number of species that can be distinguished ranging from 25 to 40 \[[@B71-molecules-21-01362],[@B72-molecules-21-01362]\], although the current consensus is thirty-three known species. Based on data available, this paper summarizes three types of terpene compositions and exhibited their bioactivities such as inhibitors of nitric oxide production, anti-tumor activity, anti-inflammatory effects, anti-oxidative effects, anti-aggregatoryand and anti-coagulative effects, sedative and analgesic activity. Taken together, the compounds from *Paeonia* plants have a great potential to be used as new chemical drugs in future. However, only nine species of the genus *Paeonia* have been chemically studied, it should be urgent to study other species for more potential bioactive components. In addition, the relationships between the species also need to be further clarified.
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Chemical structures of monoterpene glycosides.

![](molecules-21-01362-g003a)

![](molecules-21-01362-g003b)

![](molecules-21-01362-g003c)

###### 

Chemical structures of triterpenes.
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